The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: Yes, I'm here. Can you hear me?
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: That's great. Just following up on the working capital, which I just asked about. Can you maybe give some flavor on how we should look at this in
Q4? And maybe also give some more flavor on the working capital potential improvements in GPV, should we see absolute improvements in
working capital as realistic for GPV? That's the first...
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: And for BioMar on working capital, where do you see the key potential for continued improvement here?
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: That's clear. But just to be sure and to follow up, where is the continued improvement potential in BioMar for working capital?
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: Makes sense. And then just 1 last from my side. That's on Enics integration because you mentioned you already see good synergies here. Can you
maybe quantify how much that is? And also what drives these early synergies already from Enics?
Question: AndrT Thormann - Danske Bank A/S, Research Division - Analyst
: And can you quantify how much the synergy is -- have been.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
NOVEMBER 14, 2023 / 2:30PM, SCHO.CO - Q3 2023 Schouw & Co A/S Earnings Call
| 
